Deborah J. Andrews
Executive VP & CFOMs. Deborah J. Andrews is Chief Financial Officer of STAAR Surgical Company since June 25, 2025 and was its Interim Co-Chief Executive Officer since February 1, 2026 until August 04, 2026 and serves as its Executive VP since August 04, 2026. She was Interim Chief Financial Officer of STAAR Surgical Company from March 17, 2025 to June 25, 2025. Ms. Andrews served as the Chief Financial Officer of STAAR Surgical Company since September 2017 until June 2020. Ms. Andrews had been Interim Chief Financial Officer of STAAR Surgical AG from April 2017 to September 2017. She served as Interim Chief Financial Officer of STAAR Surgical Company since April 5, 2017 until October 2, 2017. Ms. Andrews served as the Chief Accounting Officer of STAAR Surgical Company since September 2013 until April 2017 and served as its Vice President since April 2005 until September 2013 and had also been its Interim Chief Financial Officer since April 28, 2017. Ms. Andrews has been a Member of the financial reporting team at STAAR Surgical for more than 10 years. Ms. Andrews served as the Chief Financial Officer of STAAR Surgical Company from August 2005 to September 2013 and Vice President of International Finance from 1999 to 2001. She served as the Chief Financial Officer of STAAR Surgical AG from 2005 to September 9, 2013. Ms. Andrews served as an Interim Chief Financial Officer of STAAR Surgical Company from April 2005 to August 2005 and as its Principal Accounting Officer since April 2005. Ms. Andrews served in a variety of financial management positions of escalating responsibility within STAAR Surgical. From 2001 to 2005, she served as a Global Controller of STAAR Surgical Company. She served as Vice President of Finance at STAAR Surgical AG (Switzerland) from 1999 to 2001. Ms. Andrews began her tenure at STAAR Surgical as the Assistant Controller from 1995 to 1999. Ms. Andrews served as an Internal Auditor for Bourns, Inc. from 1994 to 1995. She began her career in finance as an Auditor for KPMG Peat Marwick. She has been employed by STAAR since 1995, served as Principal Financial Officer from April 2005 to August 2005. She served as an Auditor for KPMG Peat Marwick from 1991 to 1994. Ms. Andrews worked as a senior accountant for a major public accounting firm. She has been an Independent Director of Lineage Cell Therapeutics, Inc. since April 11, 2014. She joined the Lineage Cell Therapeutics, Inc. on April 11, 2014. Ms. Andrews holds a Bachelor of Science degree in Accounting from California State University at San Bernardino.
公司职务
- 公司名称STAAR Surgical Company股票代码STAA职务Executive VP & CFO共事同僚
- WFWarren FoustCEO, President & Director
- NCNeal Clifton BradsherIndependent Chairman of the Board
- MMMagda MichnaChief Development Officer
- BPBen ParkChief Technology Officer
- CJConnie JohnsonDirector of Investor Relations
- LELouis E. SilvermanIndependent Director
- LYLilian Y. ZhouIndependent Director
- BWBrian WilliamsMember of Optometric Advisory Council
- 公司名称Lineage Cell Therapeutics, Inc.股票代码LCTX职务Independent Director共事同僚
- BMBrian M. CulleyCEO, President & Director
- MHMichael H. MulroyIndependent Chairman
- JAJill Ann HoweChief Financial Officer
- GAGeorge A. SamuelGeneral Counsel & Company Secretary
- ICIoana C. HoneVP of Corporate Communications & Director of Investor Relations
- CHCharlotte HubbertVice President of Corporate Strategy & Development
- NCNeal Clifton BradsherIndependent Director
- DJDeborah J. AndrewsIndependent Director
- ACAngus C. RussellIndependent Director
